Clinical utility of EDACS-ADP in patients admitted with chest pain to an emergency department


Creative Commons License

Akbas I., ÇAKIR Z., KOÇAK A. O., Ünlü A., Can N. O., Vural M., ...Daha Fazla

Disaster and Emergency Medicine Journal, cilt.6, sa.1, ss.33-40, 2021 (Scopus) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 6 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5603/demj.a2021.0008
  • Dergi Adı: Disaster and Emergency Medicine Journal
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.33-40
  • Anahtar Kelimeler: ADP, Chest pain, Chest pain score, EDACS
  • Atatürk Üniversitesi Adresli: Evet

Özet

© 2021 Via Medica.Introduction: Acute coronary syndrome (ACS) is a common cause of mortality and morbidity. An ACS diagnosis can be made with electrocardiogram (ECG) and cardiac markers. However, despite medical advances, 2-5% of ACS patients are undiagnosed and discharged from emergency departments (EDs) because clinicians often find it difficult not only to diagnose and treat high-risk patients but also to define nonemergency diseases or safely discharge healthy patients. Risk stratification can be prevented, and inappropriate diagnosis and treatment protocols can be identified. The ED Assessment of Chest Pain Score-Accelerated Diagnostic Protocol (EDACS-ADP) scoring system, developed to identify patients with chest pain but at low risk for a major adverse cardiac event (MACE), is the first score based on clinical data from emergency medicine. Aim: This study investigates the usability of EDACS-ADP in Turkey. Material and Methods: This is a prospective observational study of 392 patients. The primary outcome was a major adverse cardiovascular event (MACE) within thirty days. Results: A total of 116 MACEs occurred in 65 (16,6%) patients during a one-month follow-up. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (+ LR), and negative likelihood ratio (-LR) values of the EDACS-ADP score for the evaluation of 30-day MACE rate in patients who admitted with chest pain for two months were as follows: 96.9%, 64.5%, 35.2%, 99.1%, + LR: 2.73, and -LR: 0.05. Conclusions: Most of these patients were classified by the EDACS-ADP as low risk and suitable for discharge. The 30-day MACE rate of development was significantly low (0.9%) and acceptable in patients grouped as low risk.